Quantitative Neuroactive Metabolite Assays for Microbial Strains

Our assays transition your research from predictive genomics to definitive functional validation. By employing highly sensitive HPLC and LC-MS/MS techniques, we provide exact absolute quantification (e.g., in µg/mL or ng/mL) of critical neuroactive metabolites like GABA, serotonin (5-HT), and specific indole derivatives synthesized by your microbial strains. Furthermore, we deliver comprehensive production curves across multiple growth phases, effectively documenting not just whether a strain can produce a metabolite, but exactly how much and under what specific optimized conditions. This biochemical proof is vital for advancing mechanistic claims in regulatory submissions and patent applications.

Reproducibility is anchored in our stringent adherence to standardized cultivation methodologies and fully validated analytical workflows. Before proceeding to sample analysis, our chromatographic methods undergo validation checking for matrix effects and recovery rates utilizing stable isotope-labeled internal standards where applicable. Additionally, we precisely document all upstream variables—including media composition, specific precursor doping ratios, temperature, and pH trajectories—guaranteeing that the biochemical outputs are highly reliable and can inform your downstream scaling.

While mass spectrometry identifies the chemical structure uniformly regardless of origin, we achieve differentiation through sophisticated experimental design. For pure in vitro microbial fermentations, all detected metabolites are exclusively microbe-derived. When analyzing complex ex vivo co-cultures or in vivo fecal/tissue samples, we employ stringent vehicle controls, germ-free animal baselines, and optional targeted stable isotope tracing. This robust comparative approach allows us to confidently attribute the measured neuroactive metabolite fluctuations directly to the metabolic activity of the introduced strain or its modulation of host pathways.

Our advanced analytical platforms are exceptionally versatile and capable of handling diverse biological matrices. We routinely process sterile culture supernatants, whole-cell lysates, and complex multi-strain bioreactor media. For translational and preclinical investigations, our LC-MS/MS workflows are highly optimized with specialized protein precipitation and solid-phase extraction (SPE) protocols to cleanly analyze challenging matrices such as fecal water, mucosal washings, blood plasma/serum, and specific host tissues.